Use of cytokine therapy in primary immunodeficiency

Clinical Reviews in Allergy and Immunology

Volumn 38, Issue 1, 2010, Pages 39-53

  Roy Ghanta, Sumita ^a   Orange, Jordan S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cytokine; Granulocyte colony stimulating factor (G CSF); Granulocyte macrophage colony stimulating factor (GM CSF); Interferon alpha (IFN ); Interferon gamma (IFN ); Interleukin 2 (IL 2); Primary immunodeficiency; Therapy

Indexed keywords

CONSENSUS INTERFERON; GAMMA1B INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ALBERS SCHOENBERG DISEASE; BONE PAIN; CHRONIC GRANULOMATOUS DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CUTANEOUS NECROTIC VASCULITIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEVER; FLU LIKE SYNDROME; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; KIDNEY CARCINOMA; MEDULLARY PAIN; MELANOMA; NEOPLASM; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIMARY IMMUNODEFICIENCY; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SEVERE CONGENITAL NEUTROPENIA; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT INDICATION; VASCULITIS;

CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON-GAMMA; NEUTROPENIA; TREATMENT OUTCOME;

EID: 75949102905     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8131-4     Document Type: Review

References (88)

1. KM Zsebo AM Cohen, et al. 1986 Recombinant human granulocyte colony stimulating factor: molecular and biological characterization Immunobiology 172 3-5 175 184 1:CAS:528:DyaL2sXhs1ymsw%3D%3D 3492428
2. D Metcalf 1997 The molecular control of granulocytes and macrophages Ciba Found Symp 204 40 50 1:CAS:528:DyaK2sXls1Oksro%3D 9107409 discussion 50-46
3. K Schroder PJ Hertzog, et al. 2004 Interferon-gamma: an overview of signals, mechanisms and functions J Leukoc Biol 75 2 163 189 10.1189/jlb.0603252 1:CAS:528:DC%2BD2cXhsFKntrk%3D 14525967 (Pubitemid 38174573)
4. S Thitinan JT McConville 2009 Interferon alpha delivery systems for the treatment of hepatitis C Int J Pharm 369 121 135 10.1016/j.ijpharm.2008.11.027 1:CAS:528:DC%2BD1MXisVCgsrk%3D 19103271
5. KA Smith MF Favata, et al. 1983 Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics J Immunol 131 4 1808 1815 1:CAS:528:DyaL3sXlsFKmtL8%3D 6352804
6. K Wriedt E Kauder, et al. 1970 Defective myelopoiesis in congenital neutropenia N Engl J Med 283 20 1072 1077 1:STN:280:DyaE3M%2FgvVSiug%3D%3D 5470848
7. B Weston RF Todd 3rd, et al. 1991 Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor J Lab Clin Med 117 4 282 290 1:STN:280: DyaK3M7osF2ksQ%3D%3D 1707086
8. K Welte C Zeidler, et al. 1990 Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia Blood 75 5 1056 1063 1:STN:280:DyaK3c7mslaltA%3D%3D 1689595
9. LA Boxer R Hutchinson, et al. 1992 Recombinant human granulocyte-colony- stimulating factor in the treatment of patients with neutropenia Clin Immunol Immunopathol 62 1 Pt 2 S39 S46 10.1016/0090-1229(92)90039-Q 1:STN:280: DyaK387gtlyhsg%3D%3D 1370264
10. DC Dale MA Bonilla, et al. 1993 A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia Blood 81 10 2496 2502 1:STN:280:DyaK3s3lslKltA%3D%3D 8490166
11. R Kostmann 1956 Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria Acta Paediatr Suppl 45 Suppl 105 1 78 1:STN:280:DyaG28%2FnvV2lug%3D%3D 13326376
12. M Germeshausen M Grudzien, et al. 2008 Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations Blood 111 10 4954 4957 10.1182/blood-2007-11-120667 1:CAS:528:DC%2BD1cXmtlaiurc%3D 18337561
13. MA Bonilla AP Gillio, et al. 1989 Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis N Engl J Med 320 24 1574 1580 1:STN:280:DyaL1M3mtF2lsA%3D%3D 2471075
14. AR Page RA Good 1957 Studies on cyclic neutropenia; a clinical and experimental investigation AMA J Dis Child 94 6 623 661 1:STN:280: DyaG1c%2FitV2rtQ%3D%3D 13478297
15. Guerry Dt DC Dale, et al. 1973 Periodic hematopoiesis in human cyclic neutropenia J Clin Invest 52 12 3220 3230 10.1172/JCI107522
16. DG Wright DC Dale, et al. 1981 Human cyclic neutropenia: clinical review and long-term follow-up of patients Medicine (Baltimore) 60 1 1 13 10.1097/00005792-198101000-00001 1:STN:280:DyaL3M%2FpvVejtQ%3D%3D (Pubitemid 11179567)
17. DC Dale H WPt 1988 Cyclic neutropenia: a clinical review Blood Rev 2 3 178 185 10.1016/0268-960X(88)90023-9 1:STN:280:DyaL1M%2Fislaksg%3D%3D 3052663 (Pubitemid 18227909)
18. H Hammond TH Price, et al. 1989 Treatment of cyclic neutropenia with granulocyte colony-stimulating factor N Engl J Med 320 20 1306 1311 2469956
19. T Hanada I Ono, et al. 1990 Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor Br J Haematol 75 1 135 137 10.1111/j.1365-2141.1990.tb02631.x 1:STN:280:DyaK3czivFCjug%3D%3D 1695854
20. JD Hord JA Whitlock, et al. 1997 Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature J Pediatr Hematol Oncol 19 5 443 448 10.1097/00043426- 199709000-00007 1:STN:280:DyaK2svntVSmsg%3D%3D 9329467 (Pubitemid 28076490)
21. M Wetzler M Talpaz, et al. 1990 A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia Am J Med 89 5 663 672 10.1016/0002-9343(90)90187-I 1:STN:280:DyaK3M%2FltFGquw%3D%3D 2239986 (Pubitemid 20384326)
22. M Wetzler M Talpaz, et al. 1992 Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF JAMA 267 16 2179 2180 10.1001/jama.267.16.2179 1:STN:280:DyaK383htFOksw%3D%3D 1556785
23. GA Diaz 2005 CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203 235 243 10.1111/j.0105-2896.2005.00226.x 1:CAS:528: DC%2BD2MXhvFynsLk%3D 15661033 (Pubitemid 40179704)
24. P Cernelc D Andoljsek, et al. 2000 Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis Pflugers Arch 440 5 Suppl R81 R82 10.1007/s004240000014 1:CAS:528:DC%2BD3cXnsVyhsLk%3D 11005621
25. A Etzioni HD Ochs 2004 The hyper IgM syndrome-an evolving story Pediatr Res 56 4 519 525 10.1203/01.PDR.0000139318.65842.4A 1:CAS:528: DC%2BD2cXnsFGqtr4%3D 15319456 (Pubitemid 39280902)
26. JA Winkelstein MC Marino, et al. 2003 The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients Medicine (Baltimore) 82 6 373 384 10.1097/01.md.0000100046.06009.b0 1:CAS:528:DC%2BD3sXps1ShsL8%3D (Pubitemid 37445041)
27. B Ostenstad S Giliani, et al. 1997 A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency Clin Exp Immunol 107 2 230 234 10.1111/j.1365-2249.1997.284-ce1174.x 1:STN:280:DyaK2s7ot1Oiug%3D%3D 9030857
28. WC Wang J Cordoba, et al. 1994 Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor Am J Pediatr Hematol Oncol 16 2 160 163 1:STN:280:DyaK2c3hvFOhtw%3D%3D 7513136
29. G Simon L Marodi 1995 Successful treatment of cyclic neutropenia associated with hyperimmunoglobulin M syndrome using recombinant granulocyte-colony stimulating factor Orv Hetil 136 40 2169 2172 1:STN:280:DyaK28%2FitFOrtA%3D%3D 7566951
30. ZD Jacobs JR Guajardo, et al. 2008 XLA-associated neutropenia treatment: a case report and review of the literature J Pediatr Hematol Oncol 30 8 631 634 10.1097/MPH.0b013e3181758947 18799945
31. AW Segal 1987 Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease Nature 326 6108 88 91 10.1038/326088a0 1:CAS:528:DyaL2sXhtlKrtLY%3D 3821877 (Pubitemid 17059410)
32. TJ Muhlebach HJ Feickert, et al. 1991 Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease Eur J Pediatr 150 8 575 578 10.1007/BF02072210 1:STN:280:DyaK38%2Fmtl2ltg%3D%3D 1659535
33. KE Nichols CS Ma, et al. 2005 Molecular and cellular pathogenesis of X-linked lymphoproliferative disease Immunol Rev 203 180 199 10.1111/j.0105-2896.2005.00230.x 1:CAS:528:DC%2BD2MXhvFynsL8%3D 15661030 (Pubitemid 40179702)
34. N Strnad-Trojan R Linde, et al. 2006 Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome Eur J Pediatr 165 5 348 350 10.1007/s00431-005-0062-3 16463052
35. JR Foruny R Barcena, et al. 2006 Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization Transplantation 82 2 289 290 10.1097/01.tp.0000226223.95971.e7 16858295 (Pubitemid 44126829)
36. M Bohm TA Luger, et al. 2008 Disseminated giant molluscum contagiosum in a patient with idiopathic CD4+ lymphocytopenia. Successful eradication with systemic interferon Dermatology 217 3 196 198 10.1159/000141649 18583911
37. AF Freeman SM Holland 2008 The hyper-IgE syndromes Immunol Allergy Clin North Am 28 2 277 291 10.1016/j.iac.2008.01.005 18424333 viii (Pubitemid 351540841)
38. SS Kilic F Kilicbay 2006 Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome Pediatrics 117 6 e1253 e1255 10.1542/peds.2005-2706 16651279 (Pubitemid 46071225)
39. G Ozarmagan K Didem Yazganoglu, et al. 2005 Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b Acta Derm Venereol 85 5 433 435 10.1080/00015550510030041 16159737 (Pubitemid 41345619)
40. G Souillet F Rousset, et al. 1989 Alpha-interferon treatment of patient with hyper IgE syndrome Lancet 1 8651 1384 10.1016/S0140-6736(89)92823-7 1:STN:280:DyaL1M3otVyrtg%3D%3D 2567391
41. U Benninghoff F Cattaneo, et al. 2008 Clinical improvement and normalized Th1 cytokine profile in early and long-term interferon-alpha treatment in a suspected case of hyper-IgE syndrome Pediatr Allergy Immunol 19 6 564 568 10.1111/j.1399-3038.2007.00683.x 18844858
42. G Fuentes-Paez MA Saornil, et al. 2007 CHARGE association, hyper-immunoglobulin M syndrome, and conjunctival MALT lymphoma Cornea 26 7 864 867 10.1097/ICO.0b013e31806c77d6 17667624 (Pubitemid 47220562)
43. N Shiroma T Omi, et al. 2004 A case of X-linked agammaglobulinemia with progressive encephalitis Pediatr Neurol 31 5 371 373 10.1016/j.pediatrneurol. 2004.05.007 15519123 (Pubitemid 39424207)
44. CL King JI Gallin, et al. 1989 Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma Proc Natl Acad Sci U S A 86 24 10085 10089 10.1073/pnas.86.24.10085 1:CAS:528:DyaK3cXps1Omtg%3D%3D 2513574 (Pubitemid 20030781)
45. Y Aihara M Mori, et al. 1998 Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia J Interferon Cytokine Res 18 8 561 563 10.1089/jir.1998.18.561 1:CAS:528:DyaK1cXls1amuro%3D 9726436
46. A Metin G Uysal, et al. 2004 Tuberculous brain abscess in a patient with hyper IgE syndrome Pediatr Int 46 1 97 100 10.1111/j.1328-0867.2004.01845.x 15043676 (Pubitemid 38333641)
47. YH Pung SW Vetro, et al. 1993 Use of interferons in atopic (IgE-mediated) diseases Ann Allergy 71 3 234 238 1:STN:280:DyaK3szosVSlsQ%3D%3D 8372996
48. LS Bemiller DH Roberts, et al. 1995 Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease Blood Cells Mol Dis 21 3 239 247 10.1006/bcmd.1995.0028 1:CAS:528:DyaK28XhvFClu7o%3D 8673477 (Pubitemid 26083521)
49. RS Weening GJ Leitz, et al. 1995 Recombinant human interferon-gamma in patients with chronic granulomatous disease-European follow up study Eur J Pediatr 154 4 295 298 1:STN:280:DyaK2MzjtFentQ%3D%3D 7607280
50. The International Chronic Granulomatous Disease Cooperative Study Group 1991 A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease N Engl J Med 324 8 509 516
51. BE Marciano R Wesley, et al. 2004 Long-term interferon-gamma therapy for patients with chronic granulomatous disease Clin Infect Dis 39 5 692 699 10.1086/422993 1:CAS:528:DC%2BD2cXotV2nu74%3D 15356785 (Pubitemid 39180442)
52. RC Woodman RW Erickson, et al. 1992 Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity Blood 79 6 1558 1562 1:STN:280: DyaK387ptVCqtw%3D%3D 1312372
53. TJ Muhlebach J Gabay, et al. 1992 Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins Clin Exp Immunol 88 2 203 206 1:STN:280: DyaK383ktVygsw%3D%3D 1572085
54. A Kantar N Oggiano, et al. 1994 Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease. McLeod syndrome and hyper-IgE. Case report Minerva Pediatr 46 4 157 160 1:STN:280: DyaK2czms1ekug%3D%3D 8084323
55. RA Ezekowitz MC Dinauer, et al. 1988 Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma N Engl J Med 319 3 146 151 1:STN:280:DyaL1c3mtFCmtA%3D%3D 2838754
56. A Condino-Neto PE Newburger 2000 Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation Blood 95 11 3548 3554 1:CAS:528:DC%2BD3cXjsl2isbg%3D 10828042
57. I Marchand E Mahe, et al. 2008 Disseminated BCG infection revealing X-linked severe combined immunodeficiency Ann Dermatol Venereol 135 8-9 587 590 10.1016/j.annder.2008.02.023 1:STN:280:DC%2BD1cngt1Omtw%3D%3D 18789295
58. GS Omenn 1965 Familial reticuloendotheliosis with eosinophilia N Engl J Med 273 427 432 1:STN:280:DyaF2M7jt1Oruw%3D%3D 14328107
59. L Schandene A Ferster, et al. 1993 T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome) Eur J Immunol 23 1 56 60 10.1002/eji.1830230110 1:CAS:528:DyaK3sXht1arsbY%3D 8419187 (Pubitemid 23031895)
60. MG Netea AE Brouwer, et al. 2004 Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy Clin Infect Dis 39 9 e83 e87 10.1086/425121 15494899
61. SM Holland 2001 Immunotherapy of mycobacterial infections Semin Respir Infect 16 1 47 59 10.1053/srin.2001.22728 1:STN:280:DC%2BD3MvkslOqtA%3D%3D 11309712
62. F Altare D Lammas, et al. 1998 Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection J Clin Invest 102 12 2035 2040 10.1172/JCI4950 1:CAS:528:DyaK1MXmtFKj 9854038
63. R de Jong F Altare, et al. 1998 Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients Science 280 5368 1435 1438 10.1126/science.280.5368.1435 9603733 (Pubitemid 28264837)
64. P Remiszewski B Roszkowska-Sliz, et al. 2006 Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency Respiration 73 3 375 378 10.1159/000088682 16195661 (Pubitemid 43725798)
65. T Chatila E Castigli, et al. 1990 Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes Proc Natl Acad Sci U S A 87 24 10033 10037 10.1073/pnas.87.24.10033 1:CAS:528:DyaK3MXpvFOltg%3D%3D 2263604
66. E Castigli R Pahwa, et al. 1993 Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency Proc Natl Acad Sci U S A 90 10 4728 4732 10.1073/pnas.90.10.4728 1:CAS:528:DyaK3sXksVOht7g%3D 8506326
67. R Pahwa T Chatila, et al. 1989 Recombinant interleukin 2 therapy in severe combined immunodeficiency disease Proc Natl Acad Sci U S A 86 13 5069 5073 10.1073/pnas.86.13.5069 1:STN:280:DyaL1M3ps12ntw%3D%3D 2787027
68. RA Aldrich AG Steinberg, et al. 1954 Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea Pediatrics 13 2 133 139 1:STN:280:DyaG2c%2FltlCitA%3D%3D 13133561
69. Y Jin C Mazza, et al. 2004 Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation Blood 104 13 4010 4019 10.1182/blood-2003-05-1592 1:CAS:528:DC%2BD2cXhtFaju7jO 15284122 (Pubitemid 39620151)
70. H Azuma M Oshima, et al. 2000 Impaired interleukin-2 production in T-cells from a patient with Wiskott-Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy Eur J Pediatr 159 8 633 634 10.1007/PL00008395 1:CAS:528:DC%2BD3cXksFGhsL4%3D 10968249
71. H Azuma H Sakata, et al. 1993 Effect of interleukin 2 on intractable herpes virus infection and chronic eczematoid dermatitis in a patient with Wiskott-Aldrich syndrome Eur J Pediatr 152 12 998 1000 10.1007/BF01957224 1:STN:280:DyaK2c7nvVegtA%3D%3D 8131820 (Pubitemid 23361975)
72. EP Hanson L Monaco-Shawver, et al. 2008 Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity J Allergy Clin Immunol 122 6 1169 1177 10.1016/j.jaci.2008.08.018 1:CAS:528:DC%2BD1cXhsV2ltr%2FJ 18851874 e1116
73. JS Orange SR Brodeur, et al. 2002 Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations J Clin Invest 109 11 1501 1509 1:CAS:528:DC%2BD38XktlWksr4%3D 12045264
74. C Cunningham-Rundles C Bodian 1999 Common variable immunodeficiency: clinical and immunological features of 248 patients Clin Immunol 92 1 34 48 10.1006/clim.1999.4725 1:STN:280:DyaK1Mzktl2nuw%3D%3D 10413651 (Pubitemid 29315984)
75. C Cunningham-Rundles C Bodian, et al. 2001 Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency Clin Immunol 100 2 181 190 10.1006/clim.2001.5052 1:CAS:528:DC%2BD3MXmsV2mtrc%3D 11465947 (Pubitemid 32703423)
76. JA Rump A Jahreis, et al. 1997 A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID) Clin Exp Immunol 110 2 167 173 1:CAS:528:DyaK2sXntlSrt7c%3D 9367398
77. C Cunningham-Rundles L Mayer, et al. 1992 Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2 Clin Immunol Immunopathol 64 1 46 56 10.1016/0090-1229(92)90058-V 1:STN:280: DyaK383pvVKhtA%3D%3D 1606751
78. RM Ten PM Anderson, et al. 2002 Interleukin-2 liposomes for primary immune deficiency using the aerosol route Int Immunopharmacol 2 2-3 333 344 10.1016/S1567-5769(01)00143-6 1:CAS:528:DC%2BD38Xos1Srsg%3D%3D 11811936 (Pubitemid 34075422)
79. N Flomenberg K Welte, et al. 1983 Immunologic effects of interleukin 2 in primary immunodeficiency diseases J Immunol 130 6 2644 2650 1:STN:280:DyaL3s3hsVGktw%3D%3D 6222111
80. C Herzmann Z Cuthbertson, et al. 2008 Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients J Antimicrob Chemother 62 3 583 586 10.1093/jac/dkn238 1:CAS:528:DC%2BD1cXhtVShsrrP 18587135
81. AM Taylor DG Harnden, et al. 1975 Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity Nature 258 5534 427 429 10.1038/258427a0 1:CAS:528:DyaE28Xnt1ejtQ%3D%3D 1196376
82. S Doi O Saiki, et al. 1989 Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient Eur J Pediatr 148 7 630 633 10.1007/BF00441517 1:STN:280:DyaL1MzgsFKmtw%3D%3D 2663515 (Pubitemid 19131979)
83. KE Sullivan 2008 Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome Immunol Allergy Clin North Am 28 2 353 366 10.1016/j.iac.2008.01.003 18424337
84. ML Markert DS Hummell, et al. 1998 Complete DiGeorge syndrome: persistence of profound immunodeficiency J Pediatr 132 1 15 21 10.1016/S0022-3476(98)70478-0 1:STN:280:DyaK1c7jtVOksg%3D%3D 9469994 (Pubitemid 28082525)
85. C Cunningham-Rundles HW Murray, et al. 1999 Treatment of idiopathic CD4 T lymphocytopenia with IL-2 Clin Exp Immunol 116 2 322 325 10.1046/j.1365-2249. 1999.00886.x 1:STN:280:DyaK1M3ntFSlsA%3D%3D 10337025 (Pubitemid 29219731)
86. Y Yilmaz-Demirdag B Wilson, et al. 2008 Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+) T lymphocytopenia Allergy Asthma Proc 29 4 421 424 10.2500/aap.2008.29.3143 1:CAS:528:DC%2BD1cXhtFWitLbI 18702891
87. AA Gaspari AD Zalka, et al. 1997 Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia Arch Dermatol 133 4 491 496 10.1001/archderm.133.4.491 1:STN:280:DyaK2s3ntFSlsA%3D%3D 9126013
88. S Narula DF LaRosa, et al. 2007 Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution Ann Allergy Asthma Immunol 98 5 483 489 17521034